Verve Therapeutics, Inc.

VERVDelisted Jul 25, 2025

Industry: Pharmaceutical Preparations
SEC CIK: 0001840574

SEC filings (opens in a new tab)

Verve Therapeutics, Inc. was delisted on Jul 25, 2025; its insiders filed their last Form 4 on Jul 28, 2025; 176 institutions reported holding it in 13F filings for Q2 2025, worth $819.4M in total; no superinvestor held it.

Q2 2022 vs. Q1 2022

How the institutions holding Verve Therapeutics, Inc. changed between Q1 2022 and Q2 2022.

All holders in Q2 2022 All holders in Q1 2022

13F holders of VERV: Q1 2022 compared with Q2 2022
Measure	Q1 2022	Of which not filed for Q2 2022	Q2 2022	Change
Holders	92	1	101	+10
Shares	46.6M	4.40K	45.6M	−1.07M (−2.3%)
Value	$1.06B	$100.0K	$695.8M	−$368.3M (−34.6%)

1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (27)

Institutions that held Verve Therapeutics, Inc. at the end of Q2 2022 but not at the end of Q1 2022.

Institutions new to VERV in Q2 2022
Institution	Shares	Value	% of portfolio
Millennium Management LLC	371,671	$5.68M	0.01%
Renaissance Technologies LLC	311,200	$4.75M	0.01%
Mirae Asset Global Investments Co., Ltd.	117,698	$1.80M	0.00%
Sumitomo Mitsui Trust Holdings, Inc.	115,232	$1.76M	0.00%
ExodusPoint Capital Management, LP	114,117	$1.74M	0.02%
Ergoteles LLC	74,000	$1.13M	0.03%
Occudo Quantitative Strategies LP	57,777	$883.0K	0.07%
Pinz Capital Management, LP	51,800	$792.0K	0.54%
Marshall Wace, LLP	50,499	$772.0K	0.00%
Jump Financial, LLC	37,700	$576.0K	0.02%
HRT Financial LP	36,541	$558.0K	0.01%
Gsa Capital Partners LLP	25,544	$390.0K	0.06%
Schonfeld Strategic Advisors LLC	25,381	$388.0K	0.00%
State Board of Administration of Florida Retirement System	19,320	$295.0K	0.00%
UBS Asset Management Americas Inc	15,000	$229.2K	0.00%
Voya Investment Management LLC	13,648	$209.0K	0.00%
HighTower Advisors, LLC	12,000	$184.0K	0.00%
Quantbot Technologies LP	6,500	$99.0K	0.01%
Nisa Investment Advisors, LLC	1,100	$17.0K	0.00%
US Bancorp	494	$8.00K	0.00%
Advisor Group Holdings, Inc.	500	$8.00K	0.00%
Ellevest, Inc.	221	$3.00K	0.00%
Huntington National Bank	100	$2.00K	0.00%
CWM, LLC	34	$1.00K	0.00%
Northwestern Mutual Wealth Management Co	23	$0	0.00%
Captrust Financial Advisors	4	$0	0.00%
Steward Financial Group LLC	2	$0	0.00%

Sold out (17)

Institutions that held Verve Therapeutics, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.

Institutions that sold out of VERV in Q2 2022
Institution	Shares, Q1 2022	Value, Q1 2022
Janus Henderson Group PLC	690,011	$15.7M
Ra Capital Management, L.P.	310,284	$7.08M
Rafferty Asset Management, LLC	185,009	$4.22M
Ally Bridge Group (NY) LLC	105,360	$2.40M
Deep Track Capital, LP	102,342	$2.33M
Logos Global Management LP	96,912	$2.21M
Tudor Investment Corp Et Al	24,216	$553.0K
Los Angeles Capital Management LLC	16,685	$381.0K
HighVista Strategies LLC	14,073	$321.0K
CIBC World Markets Inc.	12,474	$285.0K
Jane Street Group, LLC	12,333	$281.0K
Qube Research & Technologies Ltd	12,155	$277.0K
ProShare Advisors LLC	11,817	$270.0K
E Fund Management Co., Ltd.	9,282	$212.0K
STRS Ohio	8,600	$196.0K
Point72 Hong Kong Ltd	5,253	$120.0K
High Net Worth Advisory Group LLC	500	$11.0K

Not filed for Q2 2022 yet (1)

Institutions that held Verve Therapeutics, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding VERV in Q1 2022 that haven't filed for Q2 2022
Institution	Shares, Q1 2022	Value, Q1 2022
Amalgamated Financial Corp.	4,398	$100.0K